We now have Quarter 4 H1B visa FY 2023 data and Quarter 4 PERM visa FY 2023 data and Quarter 4 H2A visa FY 2023 data.
Employer Search tool is moved to it's own page: "H1B Visa Data Search Tool"

Statistics and Summary

Erin M Brummer has been assisting clients through the H1B Visa process since 2020.

As of 2022, Erin M Brummer has succesfully submitted and recieved certification for 150 cases.

Erin M Brummer is located in Boston, MA, and has represented 6 employers for the H1B Visa Process

151
Cases Handled
150
Cases Certified
99.34%
Approval

Cases Handled by Erin M Brummer

Case Number Case Status Job Title Industry Name Employer Name Year
I-200-20107-493902 Certified Bioinformatics Scientists Research And Development In Biotechnology Except Nanobiotechnology Intellia Theapeutics 2020
I-200-20107-493699 Certified Bioinformatics Scientists Research And Development In Biotechnology Except Nanobiotechnology Intellia Theapeutics 2020
I-200-20107-493624 Certified Bioinformatics Scientists Research And Development In Biotechnology Except Nanobiotechnology Intellia Theapeutics 2020
I-200-20107-493622 Certified Bioinformatics Scientists Research And Development In Biotechnology Except Nanobiotechnology Intellia Theapeutics 2020
I-200-20107-493621 Certified Bioinformatics Scientists Research And Development In Biotechnology Except Nanobiotechnology Intellia Theapeutics 2020
I-200-20107-493583 Certified Bioinformatics Scientists Research And Development In Biotechnology Except Nanobiotechnology Intellia Theapeutics 2020
I-200-20107-493547 Certified Bioinformatics Scientists Research And Development In Biotechnology Except Nanobiotechnology Intellia Theapeutics 2020
I-200-20107-493540 Certified Bioinformatics Scientists Research And Development In Biotechnology Except Nanobiotechnology Intellia Theapeutics 2020
I-200-20107-493500 Certified Bioinformatics Scientists Research And Development In Biotechnology Except Nanobiotechnology Intellia Theapeutics 2020
I-200-20043-319054 Certified Bioinformatics Scientists Research And Development In Biotechnology Except Nanobiotechnology Intellia Therapeutics Inc 2020